Epsilon M&A Deal Report - PhysIOL Group
Transaction Multiples for the Valuation of Private Companies
BVI (Beaver-Visitec International) / PhysIOL Group
No EMAT :
117720
Announced Date :
20/12/2018
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
BVI (Beaver-Visitec International)
Target :
PhysIOL Group
Country :
Belgium
Sector of activity :
- Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Supplies
Business Description :
Founded in 1986 at the University of Liège, PhysIOL is a Belgium-based ophthalmic company specializing in the research, development and manufacture of intraocular lenses (IOLs). > The company’s...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
|
ns |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Supplies » = 71
| Date | Acquirer | Target | Country | Multiples | See details |
| 25/04/2024 | Esteve Pharmaceuticals | HRA Pharma Rare Diseases | Hauts-De-Seine | ** | 117378 |
| 05/06/2024 | Rohto Pharmaceuticals Co | MoNo chem-pharm Produkte (Sigmapharm) | Austria | * | 117090 |
Source: Epsilon Research / EMAT
